Trademark: 98238961
Word
VYNMO
Status
Pending
Status Code
681
Status Date
Wednesday, April 24, 2024
Serial Number
98238961
Mark Type
4
Filing Date
Wednesday, October 25, 2023
Published for Opposition
Tuesday, May 28, 2024

Trademark Owner History

Classifications
5 Pharmaceutical and biological preparations for treating tenosynovial giant cell tumor (TGCT), giant cell tumor of the tendon sheath (GCT-TS), and pigmented villonodular synovitis (PVNS); Pharmaceutical and biological preparations for use in orthopedics, rheumatology, oncology, neurology, immunology, and hematology; Pharmaceutical and biological preparations for preventing, diagnosing, treating and managing diseases, disorders, and conditions affecting the musculoskeletal system, central nervous system, immune system, and blood; Pharmaceutical and biological preparations for treating tumors, sarcomas, tenosynovial giant cell tumors, graft versus host disease (GVHD), Parkinson's disease, Alzheimer's disease, and Amyotrophic Lateral Sclerosis (ALS); Therapeutic agents, namely, kinase inhibitors

Trademark Events
Oct 28, 2023
New Application Entered
Jan 12, 2024
Assigned To Examiner
Oct 31, 2023
New Application Office Supplied Data Entered
Jan 13, 2024
Non-Final Action Written
Jan 13, 2024
Non-Final Action E-Mailed
Jan 13, 2024
Notification Of Non-Final Action E-Mailed
Apr 12, 2024
Teas/Email Correspondence Entered
Apr 12, 2024
Correspondence Received In Law Office
Apr 20, 2024
Approved For Pub - Principal Register
May 8, 2024
Notification Of Notice Of Publication E-Mailed
Apr 12, 2024
Teas Response To Office Action Received

Trademark Alertz updated from USPTO on 2030-01-24